Avalo Therapeutics (AVTX) EPS (Diluted) (2015 - 2026)
Avalo Therapeutics (AVTX) EPS (Diluted) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.15 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -368,323.02 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.02 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.75 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.33 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - | -0.98 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.98 |
| Dec 31, 2025 | -1.02 |
| Sep 30, 2025 | -2.19 |
| Jun 30, 2025 | -1.92 |
| Mar 31, 2025 | -1.25 |
| Dec 31, 2024 | -4.71 |
| Sep 30, 2024 | 2.14 |
| Jun 30, 2024 | 12.87 |
| Mar 31, 2024 | -141.14 |
| Dec 31, 2023 | -29.41 |
| Sep 30, 2023 | -26.81 |
| Jun 30, 2023 | -140.62 |
| Mar 31, 2023 | -203.65 |
| Dec 31, 2021 | -5.38 |
| Sep 30, 2021 | 6.29 |
| Jun 30, 2021 | 5.71 |
| Mar 31, 2021 | -8.77 |
| Dec 31, 2020 | 41.30 |
| Sep 30, 2020 | -16.39 |
| Jun 30, 2020 | -37.66 |